BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

BioMarin (NASDAQ: BMRN) said its management team will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025 at 10:30 AM GMT in London, England.

Rhea-AI Summary

BioMarin (NASDAQ: BMRN) said its management team will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025 at 10:30 AM GMT in London, England. An audio webcast will be available live and an archived version of the remarks will be posted on the company investor website for a limited time.

Investors can access the live webcast and archive at https://investors.biomarin.com/.

Argus Nov 11 session

+4.29% close to close Open Argus

Details

News Market Reaction – BMRN

On Nov 11, the day this news came out, BMRN closed 4.29% above the previous close.

Data tracked by StockTitan Argus for the Nov 11 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Nov. 11, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England in London.

An audio webcast of the presentation will be available live. The webcast can be accessed at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-at-the-jefferies-global-healthcare-conference-on-tuesday-november-18-2025-at-1030-am-gmt-in-london-england-302610867.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will BioMarin (BMRN) present at the Jefferies Global Healthcare Conference?

BioMarin management will present on Tuesday, November 18, 2025 at 10:30 AM GMT in London.

How can I listen to the BioMarin (BMRN) presentation on November 18, 2025?

An audio webcast will be available live at https://investors.biomarin.com/.

Will BioMarin (BMRN) provide a replay of the Jefferies conference presentation?

Yes. An archived version of the remarks will be posted on the company website for a limited time after the conference.

What time is the BioMarin (BMRN) webcast for U.S. investors on November 18, 2025?

The presentation is at 10:30 AM GMT; U.S. investors should convert that to their local time zones.

Where can investors find additional details about BioMarin (BMRN) conference participation?

Details and access to the live webcast and archive are available at https://investors.biomarin.com/.